TLDR Combining α-blockers and Finasteride is useful for treating small prostate enlargement.
The study evaluated the efficacy of combining α-blockers and Finasteride for treating benign prostatic hyperplasia (BPH) in patients with a prostate volume of less than 40 grams. The research was conducted by a team from Chonnam National University and Seonam University. The combination therapy aimed to address symptoms associated with BPH, leveraging the benefits of both medications. However, specific details on the number of participants and the outcomes of the study were not provided in the document.
1 citations
,
March 2023 in “Scientific Reports” Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.
30 citations
,
September 2016 in “BMJ” Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.
15 citations
,
November 2015 in “Pharmacopsychiatry” α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.
18 citations
,
November 2012 in “Current opinion in urology” Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.
1 citations
,
March 2022 in “British Journal of Clinical Pharmacology” 5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.
14 citations
,
May 2016 in “Therapeutic advances in urology” Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.